Message Font: Serif | Sans-Serif
 
UnThreaded | Threaded | Whole Thread (2) | Ignore Thread Prev | Next
Author: LorenCobb Big gold star, 5000 posts Top Favorite Fools Top Recommended Fools Feste Award Nominee! Old School Fool Add to my Favorite Fools Ignore this person (you won't see their posts anymore) Number: of 142  
Subject: Nanotechnology for anti-H5N1 viruses Date: 10/5/2007 2:52 PM
Post New | Post Reply | Reply Later | Create Poll Report this Post | Recommend it!
Recommendations: 0
Nanoviricides (NNVC.OB) is an Indian high-tech company working with heavy infusions of venture capital to bring nanotechnology to the search for ways of attacking the H5N1 (bird flu) virus. The CEO of Nanoviricides recently made a presentation to the 5th International Bird Flu Conference on his progress to date. Here are three paragraphs from a press release on the subject:

Dr. Seymour [CEO of Nanoviricides] compared the various treatment options currently available to the practitioner working on the front lines. "Speakers from Vietnam, Indonesia and Turkey made it clear," said Seymour, that "at the present time, no good treatment options exist. These speakers complained that patients sought medical care too late for Tamiflu® — the drug currently recommended by WHO — to be effective. They also pointed out that resistance to Tamiflu develops quickly. Vaccines may be ineffective in the field due to the antigenic drift caused by the observed rapid mutation rate of the influenza virus, according to these physicians. They fear that antibodies alone also will be ineffective as drugs in the field due to the antigenic drift."

"Mutations and antigenic drift should not allow influenza viruses, even H5N1, to escape FluCide-I," said Dr. Seymour. "Similarly, FluCide-HP attacks the invariant features of the signature region that causes high pathogenicity in avian influenza viruses such as H5N1 and H7N3. If a high path virus learns to evade FluCide-HP, it would have lost this signature, and would therefore no longer be highly pathogenic. Thus it would pose only a minimal threat as a pandemic agent," he added.

"We are now working on the necessary paperwork with an agency to begin animal studies against the highly pathogenic H5N1 virus," he reported.


Loren

Disclosure: I own 600 shares of Nanoviricides.
Post New | Post Reply | Reply Later | Create Poll Report this Post | Recommend it!
Print the post  
UnThreaded | Threaded | Whole Thread (2) | Ignore Thread Prev | Next

Announcements

Foolanthropy 2014!
By working with young, first-time moms, Nurse-Family Partnership is able to truly change lives – for generations to come.
When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Post of the Day:
Macro Economics

The Story Behind the Story
What was Your Dumbest Investment?
Share it with us -- and learn from others' stories of flubs.
Community Home
Speak Your Mind, Start Your Blog, Rate Your Stocks

Community Team Fools - who are those TMF's?
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and "#1 Media Company to Work For" (BusinessInsider 2011)! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.
Advertisement